Proteomics

Dataset Information

0

Reduced Nicotinamide Mononucleotide (NMNH) Potently Enhances NAD+, Suppresses Glycolysis and Cell Growth


ABSTRACT: In the present study, we developed a chemical method to produce dihydro nicotinamide mononucleotide (NMNH), which is the reduced-form of nicotinamide mononucleotide (NMN). We demonstrated that NMNH was a better nicotinamide adenine dinucleotide (NAD+) enhancer compared to NMN both in vitro and in vivo mediated by mononucleotide adenylyltransferase (NMNAT). Additionally, NMNH increased the reduced NAD (NADH) levels in cells and in mouse liver. Metabolomic analysis revealed that NMNH inhibited glycolysis and TCA cycle. In vitro experiments demonstrated that NMNH induced cell cycle arrest and suppressed cell growth. Nevertheless, NMNH treatment did not cause observable difference in mice. Taken together, our work demonstrates that NMNH is a potent NAD+ enhancer, and suppresses glycometabolism and cell growth.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Hepatocyte, Cell Culture

DISEASE(S): Disease Free

SUBMITTER: Yan Liu  

LAB HEAD: Haiteng Deng

PROVIDER: PXD022547 | Pride | 2022-02-25

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
MS192508_H_.msf Msf
MS192508_H_1.raw Raw
MS192508_H_10.raw Raw
MS192508_H_11.raw Raw
MS192508_H_12.raw Raw
Items per page:
1 - 5 of 14

Similar Datasets

2011-12-05 | E-GEOD-31647 | biostudies-arrayexpress
2011-12-05 | GSE31647 | GEO
2023-06-03 | GSE233644 | GEO
2010-05-14 | E-GEOD-18909 | biostudies-arrayexpress
2023-09-20 | E-MTAB-13187 | biostudies-arrayexpress
2010-02-24 | GSE18909 | GEO
2019-01-01 | GSE118365 | GEO
2021-05-01 | GSE157988 | GEO
2016-12-01 | GSE85718 | GEO
2009-05-28 | GSE13577 | GEO